New: Webinar: The future of HCP engagement strategies at congress

Register now
Onomi by SpotMe
About Onomi

The live engagement intelligence layer for pharma.

Onomi captures what HCPs actually say and do at your congresses, webinars, advisory boards, and medical education meetings — resolves every interaction to a CRM identity, and feeds your Veeva or Salesforce timeline with the behavioral signals your omnichannel engine has never been able to see.

Talk to us
Veeva Product Partner — SilverSalesforce PartnerSOC 2 Type 2ISO 27001 (Bureau Veritas)CSA STARHIPAA
What we do, in one sentence

Onomi is the live engagement intelligence layer for pharma.

Onomi is a software platform that captures what happens at every live HCP interaction — congresses, webinars, advisory boards, medical education meetings — resolves each interaction to a CRM identity, and pushes rich, structured behavioral signals into the CRM in time to drive the next commercial or medical action.

Three products sit underneath that single architecture. All three feed one identity-resolution engine, one consent framework, and one sync into a CRM.

Why we built it

Pharma built a brilliant omnichannel model. And left one channel out of it.

Pharma commercial teams have spent the last five years building real omnichannel orchestration. CRM. Marketing automation. Next-best-action AI. A content factory feeding the field.

And the richest behavioral signal in the entire channel mix — what an HCP asks at a booth, submits in a webinar Q&A, raises in an advisory board, or scores poorly on in a pre-session assessment — still doesn't reach CRM. At best, it reaches people three weeks late, in a PowerPoint, with no identity resolution and no way to trigger anything downstream.

The result: reps walk in cold. Brand teams design campaigns from assumed pain, not stated pain. MSLs lose KOL context the moment a meeting ends. Agentic AI personalizes from incomplete profiles.

We built Onomi to close that gap — at the speed, scale, and rigor a Top 20 pharma operates at.

Where Onomi comes from

Twenty-plus years building the most demanding pharma engagement programs in the world.

Onomi is the life sciences engagement business of SpotMe, a Lausanne-based platform founded in 2000 as a spin-off from the École Polytechnique Fédérale de Lausanne (EPFL) — one of Europe's leading engineering universities. For more than two decades, the platform has run mission-critical scientific exchanges for the world's largest pharmaceutical organizations.

Since March 2023, Onomi has been part of Swiss Post Digital Services — the digital communications division of Switzerland's national communications institution. The logic was clear: for more than 175 years, Swiss Post has been the trusted custodian of Switzerland's most sensitive communications. Extending that mandate into the secure, identity-resolved exchange of enterprise data was a natural next step. It is also why, when a Top 20 pharma's procurement team asks about data governance, parent-company stability, and long-term continuity, the answer is unusually short.

2000
EPFL spin-off
Founded in Lausanne as a spin-off from the École Polytechnique Fédérale de Lausanne.
2023
Swiss Post Digital Services
Joined the digital communications division of Switzerland's national communications institution.
2024
Onomi
Life sciences engagement business launched under the Onomi brand.
Who we serve

The largest life sciences organizations in the world run on Onomi.

Onomi serves the top 20 global pharmaceutical companies and the most demanding life sciences teams in North America and Europe — across commercial, medical affairs, omnichannel, IT, and congress operations.

500,000+
HCPs engaged through Onomi monthly
30,000+
HCP engagement moments delivered each year
80–90%
identity match rate against Veeva Link / NPI on Tier 1 congresses
10+ of top 20
global pharma customers
The companies running Onomi today
AstraZenecaSanofiGSKTakedaBristol Myers SquibbBioNTechViiV HealthcareShionogiNordic PharmaBe One GroupZuellig Pharma
How we are built

Built for the requirements of regulated, enterprise pharma.

Parent organization

Part of Swiss Post Digital Services since March 2023. Founded 2000 as an EPFL spin-off.

CRM partnerships

Veeva Silver Partner · Salesforce ISV Partner. Native managed-package integrations certified by both, in production across multiple Top 20 pharma instances.

Security & compliance

SOC 2 · ISO 27001 · GDPR · HIPAA. Dedicated Trust Hub for InfoSec, DPA, and third-party risk reviews.

Global operations

Four offices across Chicago, Lausanne, Sofia, and Singapore. Supporting customers across the Americas, EMEA, and Asia Pacific.

Audited and certified
SOC 2 Type 2ISO 27001 (Bureau Veritas)GDPRCSA STARHIPAA
Where we operate

Four offices across three regions, with delivery teams supporting customers in every major pharma market.

Chicago office
Americas

SpotMe Inc. d/b/a Onomi

935 W Chestnut St, Suite #515
Chicago, IL 60642
Lausanne office
EMEA & Headquarters

SpotMe SA d/b/a Onomi

Avenue du Théâtre 1, 4th floor
1005 Lausanne, Switzerland
Sofia office
EMEA Operations

SpotMe EOOD d/b/a Onomi

Henrik Ibsen 17
1407 Sofia, Bulgaria
Singapore office
Asia Pacific

SpotMe Pte. Ltd. d/b/a Onomi

16 Raffles Quay, #33-03 Hong Leong Building
Singapore 048581
The people

The team behind every Onomi deployment.

Enterprise pharma engagements are run by people, not platforms. The Onomi team brings decades of life sciences program experience to every customer — solution architects certified on Veeva and Salesforce, program managers embedded in your congress calendar, account directors who have been doing this since before "omnichannel" was a category.

Leadership
Pierre Metrailler
Pierre Metrailler
CEO

Joined the company in 2001 and led its pivot from networking hardware to SaaS, then to a CRM-first engagement platform for life sciences. 20+ years building event tech for enterprise customers. EPFL and INSEAD.

Daphné Rapin
Daphné Rapin
CFO

Previously at Mazars and several tax / accounting consultancies before driving Onomi's transition to a SaaS business model. 15+ years in finance and accounting, scaling reporting for an international SaaS company.

Wojciech Krawiec
Wojciech Krawiec
VP Product

Previously VP Product and Technology at Skill Dynamics and co-founder of In'saneLab. 15 years delivering B2B SaaS web and mobile products, now focused on reducing friction between tech and life science companies to maximize HCP engagement.

Marc Rochat
Marc Rochat
VP Engineering

Previously held technical leadership roles at Kudelski Group and FIS before leading engineering at Onomi. 20+ years building scalable, compliant SaaS platforms with deep expertise in video and streaming for virtual and hybrid events.

Alice Thoonsen
Alice Thoonsen
VP Account Management

Previously at EY before leading global account retention and expansion at Onomi. 10+ years in program management and customer success, with deep relationship expertise across life science clients.

Olivier Aubert
Olivier Aubert
VP Business Development

Previously at KPMG and NBN before leading partnerships and enterprise acquisition at Onomi. 12+ years in enterprise sales, corporate strategy, and management consulting across seven countries. McGill grad.

Plus the team behind every deployment: account directors, solution architects, and program managers across Switzerland, France, Portugal, Chicago, and Boston — supporting your pharma engagements end-to-end.

What we believe

Five principles. No more.

  1. 01

    Live HCP engagement is the richest behavioral signal in pharma — and the one channel the omnichannel model has never been able to see. Closing that blind spot is the work.

  2. 02

    HCPs are not like other audiences. Generic engagement and event management tools fail them. Time-pressed, evidence-driven, skeptical of commercial framing, and dependent on peer credibility — pharma engagement has to be built around how clinicians actually learn, not retrofitted from a B2B SaaS playbook.

  3. 03

    An interaction that doesn't reach CRM didn't happen. A booth conversation, a webinar Q&A, an advisory board insight is only as valuable as the next action it triggers in the field.

  4. 04

    Agentic AI is only as good as the signal it ingests. Identity resolution is non-negotiable. The 2026 commercial model runs on context. Context comes from live engagement, or it comes from nowhere.

  5. 05

    Pharma commercial teams don't need another event app. They need a unified engagement intelligence layer. That is what we build.

Where we're going

The 2026 commercial model runs on context. We're building the context layer.

The next five years of pharma commercial belong to the teams that compound HCP context across every live touchpoint — and feed it into the AI agents, next-best-action engines, and CRM workflows that drive every campaign, every rep call, every MSL conversation.

That is the work Onomi 360 is built for: an identity-resolved profile per HCP, compounding across congresses, webinars, advisory boards, and medical education meetings — every interaction enriching the next. The structured upstream signal that makes agentic AI actually intelligent. The audience intelligence and KOL database that turns live engagement from a series of one-off moments into a permanent, growing commercial asset.

That's the next horizon. We're already shipping toward it.

See what live engagement intelligence looks like in your stack.

A 30-minute conversation with our team. We'll map your current live engagement layer to Onomi's architecture and show you what it would look like in Veeva or Salesforce.